GLIEMPAFLOZIN SITA 25/100
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Empagliflozin 25mg, Sitagliptin 100mg
Rs 279.65
MRP Rs 399.50
(30% OFF)
Includes all taxes
Package SIZE
( FOR 10 TABLETS )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
Buy Empagliflozin 25mg, Sitagliptin 100mg Tablets
GLIEMPAFLOZIN SITA 25/100 Tablets by Steris Healthcare Pvt Ltd is a prescription-based combination medicine containing Empagliflozin 25mg and Sitagliptin 100mg, used as part of a comprehensive treatment plan for managing Type 2 Diabetes Mellitus.
This dual-action formulation combines two advanced antidiabetic agents that work through different mechanisms to help improve blood glucose control. Empagliflozin belongs to the SGLT2 inhibitor class, while Sitagliptin belongs to the DPP-4 inhibitor class.
Manufactured under WHO-GMP certified quality standards, GLIEMPAFLOZIN SITA 25/100 is designed to provide consistent quality, safety, and therapeutic reliability when prescribed by healthcare professionals.
What is Empagliflozin 25mg + Sitagliptin 100mg?
Empagliflozin 25mg and Sitagliptin 100mg Tablets are combination oral antidiabetic medicines prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, and other diabetes management approaches are not sufficient to achieve desired blood sugar control.
The combination contains:
Empagliflozin 25mg
Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor. It works by reducing glucose reabsorption in the kidneys, allowing excess glucose to be removed from the body through urine.
Sitagliptin 100mg
Sitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor. It helps increase levels of incretin hormones, which support insulin release after meals and help regulate blood glucose levels.
Together, these medicines provide complementary glucose-lowering effects.
Uses of Empagliflozin 25mg + Sitagliptin 100mg Tablets
Doctors may prescribe this combination for:
- Management of Type 2 Diabetes Mellitus
- Improving blood glucose control along with diet and exercise
- Patients requiring combination therapy for diabetes management
- Supporting better glycemic control when single medicines are insufficient
This medicine is not intended for treating Type 1 Diabetes or diabetic ketoacidosis unless specifically directed by a healthcare professional.
How Does Empagliflozin + Sitagliptin Work?
GLIEMPAFLOZIN SITA 25/100 works through two different pathways:
Action of Empagliflozin
Empagliflozin blocks SGLT2 proteins in the kidneys. Normally, these proteins help reabsorb glucose back into the bloodstream. By blocking this process, empagliflozin increases glucose elimination through urine.
Action of Sitagliptin
Sitagliptin prevents the breakdown of incretin hormones. This allows incretins to remain active longer, helping the pancreas release insulin when blood sugar levels are elevated and reducing glucose production by the liver.
The combined action helps provide improved blood sugar management in eligible patients.
Benefits of Empagliflozin 25mg + Sitagliptin 100mg Tablets
Key benefits include:
- Dual mechanism of action for Type 2 diabetes management
- Helps improve blood glucose control
- Supports post-meal and fasting glucose regulation
- Convenient combination therapy
- Reduces the need for multiple separate medicines
- Manufactured under WHO-GMP certified standards
- Reliable pharmaceutical quality from Steris Healthcare Pvt Ltd
Directions for Use
Take GLIEMPAFLOZIN SITA 25/100 Tablets exactly as prescribed by your doctor.
General instructions:
- Swallow the tablet with water.
- Take the medicine at the recommended time.
- Follow the dosage schedule provided by your healthcare professional.
- Continue diet and exercise recommendations during treatment.
- Do not stop or change the dose without medical advice.
Regular monitoring of blood glucose levels is important during treatment.
Possible Side Effects
Like all medicines, Empagliflozin and Sitagliptin combination tablets may cause side effects in some individuals.
Common side effects may include:
- Increased urination
- Urinary tract infections
- Genital infections
- Nausea
- Stomach discomfort
- Headache
- Mild digestive symptoms
Seek medical advice immediately if you experience:
- Severe dehydration
- Signs of allergic reaction
- Persistent abdominal pain
- Symptoms of diabetic ketoacidosis
- Severe weakness or unusual tiredness
Precautions and Warnings
Before taking GLIEMPAFLOZIN SITA 25/100, inform your doctor if you have:
- Kidney disease
- Liver problems
- History of urinary infections
- Pancreatic problems
- Heart-related conditions
- Dehydration concerns
- Any medicine allergies
Additional precautions:
- Maintain adequate fluid intake as advised.
- Regular kidney function monitoring may be required.
- Inform your doctor about all medicines and supplements you are taking.
- Pregnant or breastfeeding women should use this medicine only under medical advice.
Storage Instructions
Store GLIEMPAFLOZIN SITA 25/100 Tablets:
- At room temperature
- Away from moisture and direct sunlight
- Keep in the original packaging
- Keep out of reach of children
- Do not use after the expiry date
Why Choose Empagliflozin 25mg + Sitagliptin 100mg by Steris Healthcare?
Steris Healthcare Pvt Ltd is committed to delivering quality pharmaceutical solutions manufactured under strict quality control systems.
GLIEMPAFLOZIN SITA 25/100 combines two established diabetes management molecules in one convenient formulation. Manufactured under WHO-GMP certified standards, it ensures reliable quality and consistency for healthcare professionals and patients requiring prescription-based diabetes therapy.
Frequently Asked Questions
1. What is Empagliflozin 25mg + Sitagliptin 100mg used for?
It is used along with diet and exercise to help manage blood sugar levels in adults with Type 2 Diabetes Mellitus.
2. What is Empagliflozin 25mg + Sitagliptin 100mg?
GLIEMPAFLOZIN SITA 25/100 is a combination diabetes medicine containing Empagliflozin 25mg and Sitagliptin 100mg, marketed by Steris Healthcare Pvt Ltd.
3. How does Empagliflozin help control blood sugar?
Empagliflozin helps lower blood glucose by increasing the removal of excess glucose through urine.
4. How does Sitagliptin work?
Sitagliptin increases incretin activity, helping regulate insulin release and blood glucose levels.
5. Can Empagliflozin and Sitagliptin be taken together?
Yes, this combination may be prescribed by doctors when dual therapy is required for Type 2 diabetes management.
6. Is Empagliflozin 25mg + Sitagliptin 100mg safe?
It should be used only under medical supervision. Your doctor will consider your health condition before prescribing it.
7. Does this medicine require a prescription?
Yes, GLIEMPAFLOZIN SITA 25/100 is a prescription-only medicine and requires a valid prescription.
8. Can I stop taking this medicine when my sugar levels improve?
No. Continue taking the medicine as prescribed. Stopping treatment without medical advice may affect blood sugar control.
9. Who should avoid Empagliflozin and Sitagliptin?
Patients with certain kidney problems, Type 1 diabetes, or specific medical conditions should consult their doctor before use.
10. Why choose Empagliflozin 25mg + Sitagliptin 100mg by Steris Healthcare?
GLIEMPAFLOZIN SITA 25/100 is manufactured under WHO-GMP certified standards by Steris Healthcare Pvt Ltd, offering trusted quality and consistent diabetes management support.
Product Information Table
| Product Details | Information |
|---|---|
| Brand Name | GLIEMPAFLOZIN SITA 25/100 |
| Composition | Empagliflozin 25mg + Sitagliptin 100mg |
| Dosage Form | Tablets |
| Pack Size | Strip of 10 Tablets |
| Marketed By | Steris Healthcare Pvt Ltd |
| Manufacturing Standard | WHO-GMP Certified |
| Therapeutic Category | Oral Antidiabetic Medicine |
| Prescription Status | Valid Prescription Required |